Augmentation Vs. Switch Approaches for Treatment-Resistant Depression in Older Adults: Methods and Main Results From the Optimum Study and Considerations for Ketamine in Late-Life.

Jordan F Karp

Presentation information

[CINP2024] Symposia

CINP2024 » Symposia

Symposium 21
Late-Life Treatment Resistant Depression: Advances in pharmacotherapy, brain stimulation, and brain-based mechanisms of treatment response variability.

Sun. May 26, 2024 10:45 AM - 12:00 PM Room 2 (Hall B7 (1))

Chair: Jordan F Karp (Tucson, University of Arizona)

[IS21-1] Augmentation Vs. Switch Approaches for Treatment-Resistant Depression in Older Adults: Methods and Main Results From the Optimum Study and Considerations for Ketamine in Late-Life.

*Jordan F Karp^1,2 (1. 1Department of Psychiatry, College of Medicine – Tucson, University of Arizona, Tucson, AZ, 2. 2Banner University Medical Center and Group, Tucson, AZ)

Keywords:Depression, Treatment resistant depression, Geriatric, Well-being, Falls

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Presentation information

Symposium 21Late-Life Treatment Resistant Depression: Advances in pharmacotherapy, brain stimulation, and brain-based mechanisms of treatment response variability.

[IS21-1] Augmentation Vs. Switch Approaches for Treatment-Resistant Depression in Older Adults: Methods and Main Results From the Optimum Study and Considerations for Ketamine in Late-Life.

Password

Symposium 21
Late-Life Treatment Resistant Depression: Advances in pharmacotherapy, brain stimulation, and brain-based mechanisms of treatment response variability.